Business
Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences
THE WOODLANDS, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in an upcoming fireside chat at the 2026 Leerink Partners Global Healthcare Conference in Miami on Wednesday, March 11, at 10:00 a.m. Lexicon will also be participating in 1x1 investor meetings at the 2026 Jefferies Biotech on the Beach Summit, March 10–11, and at the Barclays 28th Global Healthcare Conference, March 10-12. A live recordin
About this update from Lexicon Pharmaceuticals, Inc.
[{"type":"image","alt":"Lexicon Pharmaceuticals, Inc.","displaySize":"","headline":null,"caption":"Lexicon Pharmaceuticals, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":166,"height":50,"url":"https://media.zenfs.com/en/globenewswire.com/4d6e4fe42ab02751f185e7d242d7f8e8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/bhkXAP8bO_Q1Z4PDGMz_0w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTYzO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/4d6e4fe42ab02751f185e7d242d7f8e8","width":166,"height":50}},"lazy":false},{"type":"text","content":"THE WOODLANDS, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in an upcoming fireside chat at the 2026 Leerink Partners Global Healthcare Conference in Miami on Wednesday, March 11, at 10:00 a.m.","length":292,"tagName":"p"},{"type":"text","content":"Lexicon will also be participating in 1x1 investor meetings at the 2026 Jefferies Biotech on the Beach Summit, March 10–11, and at the Barclays 28th Global Healthcare Conference, March 10-12.","length":191,"tagName":"p"},{"type":"text","content":"A live recording and replay of the Leerink fireside chat can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.","length":154,"tagName":"p"},{"type":"text","content":"About Lexicon Pharmaceuticals Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.","length":456,"tagName":"p"},{"type":"text","content":"For Investor and Media Inquiries: Lisa DeFrancesco Lexicon Pharmaceuticals, Inc. [email protected]","length":128,"tagName":"p"},{"type":"text","content":"","length":0,"tagName":"p"}]